Lazard Asset Management’s Prime Medicine PRME Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-26
| Closed | – | – | 2521 |
|
|
2024
Q4 | $0 | Hold |
26
| – | – | ﹤0.01% | 2480 |
|
|
2024
Q3 | $0 | Sell |
26
-46
| -64% | – | ﹤0.01% | 2416 |
|
|
2024
Q2 | $0 | Sell |
72
-1,042
| -94% | – | ﹤0.01% | 2388 |
|
|
2024
Q1 | $7K | Sell |
1,114
-618
| -36% | -$3.88K | ﹤0.01% | 1887 |
|
|
2023
Q4 | $15K | Buy |
1,732
+62
| +4% | +$537 | ﹤0.01% | 2074 |
|
|
2023
Q3 | $15K | Buy |
1,670
+66
| +4% | +$593 | ﹤0.01% | 2129 |
|
|
2023
Q2 | $23K | Buy |
1,604
+57
| +4% | +$817 | ﹤0.01% | 2076 |
|
|
2023
Q1 | $18K | Buy |
+1,547
| New | +$18K | ﹤0.01% | 2073 |
|